ID: ALA2262422

Max Phase: Preclinical

Molecular Formula: C12H20O4

Molecular Weight: 228.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(=O)OCC1CC(CC)(CC)C(=O)O1

Standard InChI:  InChI=1S/C12H20O4/c1-4-10(13)15-8-9-7-12(5-2,6-3)11(14)16-9/h9H,4-8H2,1-3H3

Standard InChI Key:  PKFSEISCQAQPRK-UHFFFAOYSA-N

Associated Targets(Human)

GABA-A receptor; agonist GABA site 140 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 228.29Molecular Weight (Monoisotopic): 228.1362AlogP: 2.06#Rotatable Bonds: 5
Polar Surface Area: 52.60Molecular Species: HBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.65CX LogD: 2.65
Aromatic Rings: 0Heavy Atoms: 16QED Weighted: 0.68Np Likeness Score: 0.84

References

1. Ahungena A, Canney DJ.  (2005)  Synthesis and Evaluation of Homologous Analogs of Anticonvulsant 5-Substituted 3,3-Diethyl-4,5-Dighdro-2(3H)-Furanones,  14  (7): [10.1007/s00044-006-0144-4]

Source